All Stories

  1. Discrepancies in the Molecular Epidemiology of Druggable Genetic Alterations in Non-Small Cell Lung Cancer
  2. Antibody–Drug Conjugates in Lung Cancer: Promise, Progress, and Persistent Challenges
  3. Plasma SH Concentrations and Mortality in Patients with Newly Diagnosed Idiopathic Pulmonary Fibrosis
  4. Editorial: Advancements in Lung Cancer Precision Oncology Research and Treatments
  5. The prognostic role of inhalation injury in burn patients assessed by flexible bronchoscopy: a systematic review and meta-analysis
  6. Impact of Driver Genetic Alterations on Survival in Metastatic Colorectal Cancer Patients from a Genetically Homogeneous Sardinian Population: A Real-World Study
  7. Clinical Molecular Pathology and Treatment Developments in Advanced Uveal Melanoma: State of the Art
  8. KRAS mutations in non-small cell lung cancer: Translational aspects, current therapies and challenges for future research
  9. Clinical, Histopathological, Dermoscopic Features, and BRAF, NRAS, and Cell Cycle Genes’ Mutation Status in Cutaneous Melanoma
  10. The routine use of a digital tool for the tumor cell fraction quantification in molecular pathology: an international validation of QuANTUM
  11. Osteopontin in rheumatic diseases: A systematic review and meta-analysis
  12. The impact of multidisciplinary teams on overall mortality and average survival in cancer: a systematic review and meta-analysis
  13. VEGF in psoriatic arthritis: Systematic review and meta-analysis
  14. Circulating Fetuin‐A concentrations in rheumatic diseases: a systematic review and meta‐analysis
  15. Vascular endothelial growth factor in inflammatory bowel disease: A systematic review and meta‐analysis
  16. Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond
  17. Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy
  18. Resistin and omentin in breast cancer: A systematic review and meta-analysis
  19. A systematic review and meta-analysis of the diagnostic accuracy of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in systemic lupus erythematosus
  20. The association between bilirubin concentrations and inflammatory bowel disease: Insights from a systematic review and meta‐analysis
  21. Role of bronchoscopy in inhalation injury: a case report and literature review
  22. Association between blood Pentraxin‐3 concentrations and rheumatic diseases: A systematic review and meta‐analysis
  23. PD-L1 immunohistochemical expression in bladder urothelial cancer with SP263, SP142 and 22C3 antibodies: A comparative study
  24. Ischemia-Modified Albumin (IMA) Is Associated with Poor Survival in Patients with Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF): A Pilot Study
  25. Red Cell Distribution Width as a Predictor of Survival in Patients with Hepatocellular Carcinoma
  26. Digital Pathology Applications for PD-L1 Scoring in Head and Neck Squamous Cell Carcinoma: A Challenging Series
  27. Role of Blood Cell Indexes in Progresses to ESRD
  28. Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population
  29. A Systematic Review and Meta-Analysis of Mean Platelet Volume and Platelet Distribution Width in Patients with Obstructive Sleep Apnoea Syndrome
  30. Primary Ewing sarcoma of the lung: A systematic review of the recent literature
  31. Aggregate Index of Systemic Inflammation (AISI), Disease Severity, and Mortality in COVID-19: A Systematic Review and Meta-Analysis
  32. Evaluation of Inflammation and Oxidative Stress Markers in Patients with Obstructive Sleep Apnea (OSA)
  33. PD-L1 Expression in Cutaneous Angiosarcomas: A Systematic Review with Meta-Analysis
  34. Association between Red Blood Cell Distribution Width and Obstructive Sleep Apnea Syndrome: A Systematic Review and Meta-Analysis
  35. Mammary-like adenocarcinoma of the vulva: a rare case report with next generation sequencing
  36. Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma
  37. Blood Cells Count Derived Inflammation Indexes as Predictors of Early Treatment Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
  38. Current Trends in Mucosal Melanomas: An Overview
  39. Duration of Immunotherapy in Non-Small Cell Lung Cancer Survivors: A Lifelong Commitment?
  40. Liquid Biopsy in the Oncological Management of a Histologically Undiagnosed Lung Carcinoma: A Case Report
  41. How the COVID-19 pandemic has affected the colorectal cancer screening in Italy: A minireview
  42. Inflammatory Indexes as Predictive Biomarkers of Postoperative Complications in Oncological Thoracic Surgery
  43. Role of EBUS-TBNA in Non-Neoplastic Mediastinal Lymphadenopathy: Review of Literature
  44. The Aggregate Index of Systemic Inflammation (AISI): A Novel Prognostic Biomarker in Idiopathic Pulmonary Fibrosis
  45. C reactive protein to albumin ratio (CAR) as predictor of anastomotic leakage in colorectal surgery
  46. INR and COVID-19 severity and mortality: A systematic review with meta-analysis and meta-regression
  47. The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something?
  48. Blood Cell Count Indexes of Systemic Inflammation in Carotid Artery Disease: Current Evidence and Future Perspectives
  49. Asymmetric Dimethylarginine: a Key Player in the Pathophysiology of Endothelial Dysfunction, Vascular Inflammation and Atherosclerosis in Rheumatoid Arthritis?
  50. Chronic Inflammation and Cancer: The Role of Endothelial Dysfunction and Vascular Inflammation
  51. NGS-Based Analysis of Atypical Deep Penetrating Nevi
  52. Durvalumab Plus Tremelimumab in Solid Tumors: A Systematic Review
  53. Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy?
  54. Serum amyloid A concentrations, COVID-19 severity and mortality: An updated systematic review and meta-analysis
  55. The The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients
  56. Methodological Fallacies in the Determination of Serum/Plasma Glutathione Limit Its Translational Potential in Chronic Obstructive Pulmonary Disease
  57. Platelet Count and Platelet Indices in Patients with Stable and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
  58. Complete blood cell count measures in retinal artey occlusions
  59. SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives
  60. Serum albumin concentrations are associated with disease severity and outcomes in coronavirus 19 disease (COVID-19): a systematic review and meta-analysis
  61. Laparoscopic versus Open Transverse-Incision Approach for Right Hemicolectomy: A Systematic Review and Meta-Analysis
  62. Red Blood Cell Distribution Width (RDW) Correlates to the Anatomical Location of Colorectal Cancer. Implications for Clinical Use
  63. Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer
  64. The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients
  65. Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)
  66. Systematic Review and Meta-Analysis of the Blood Glutathione Redox State in Chronic Obstructive Pulmonary Disease
  67. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
  68. Diagnostic accuracy of different blood cells-derived indexes in rheumatoid arthritis
  69. Primary Melanoma of the Lung: A Systematic Review
  70. Blood Cell Count Biomarkers, Risk, and Outcomes of Ischemia-Related Lower Limb Amputations: Systematic Review
  71. Blood Cell Count Derived Inflammation Indexes in Patients with Idiopathic Pulmonary Fibrosis
  72. D-Dimer Concentrations and COVID-19 Severity: A Systematic Review and Meta-Analysis
  73. Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report
  74. Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients
  75. Repurposing anticancer drugs for the treatment of idiopathic pulmonary fibrosis and antifibrotic drugs for the treatment of cancer: state of the art
  76. Mean Platelet Volume, Red Cell Distribution Width, and Complete Blood Cell Count Indices in Retinal Vein Occlusions
  77. Resveratrol Inhibits Oxidative Stress and Prevents Mitochondrial Damage Induced by Zinc Oxide Nanoparticles in Zebrafish (Danio rerio)
  78. Reply
  79. Role of the mTOR pathway in liver cancer: from molecular genetics to targeted therapies
  80. Systemic transsulfuration pathway thiol concentrations in chronic obstructive pulmonary disease patients
  81. Epidemiology and Genetic Susceptibility of Breast and Ovarian Cancer in Sardinian Population
  82. Blood cell count indexes as predictors of anastomotic leakage in elective colorectal surgery: a multicenter study on 1432 patients
  83. Micellar electrokinetic capillary chromatographic determination of pirfenidone and 5-carboxy-pirfenidone by direct injection of plasma from patients receiving treatment for idiopathic pulmonary fibrosis (IPF)
  84. Bilirubin levels in patients with mild and severe Covid‐19: a pooled analysis
  85. Radio-Pathological Correlations in Patients with Liver Metastases for Colorectal Cancer
  86. KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors
  87. In situ reconstruction with autologous graft in the treatment of secondary aortoenteric fistulas: A retrospective case series
  88. Solitary Fibrous Tumor of the Omentum: Presentation of a Case and Literature Review
  89. Long Noncoding RNAs in Non-Small Cell Lung Cancer: State of the Art
  90. Circulating Concentrations of Key Regulators of Nitric Oxide Production in Undernourished Sheep Carrying Single and Multiple Fetuses
  91. Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma
  92. Complete blood cell count indexes in non‐arteritic anterior ischemic optic neuropathy
  93. EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma
  94. Cryoablation In The Management Of Breast Cancer: Evidence To Date
  95. BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas
  96. Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach
  97. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study
  98. Diet and melanoma
  99. A diethylpyrocarbonate-based derivatization method for the LC-MS/MS measurement of plasma arginine and its chemically related metabolites and analogs
  100. MALONDIALDEHYDE LEVELS IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION
  101. Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases
  102. Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials
  103. Effect of statin treatment on circulating malondialdehyde concentrations: a systematic review and meta-analysis
  104. Development of an LC–Tandem Mass Spectrometry Method for the Quantitative Analysis of Hercynine in Human Whole Blood
  105. Hercynine content in widely consumed commercial beverages
  106. Associations between the neutrophil-to-lymphocyte and the platelet-to-lymphocyte ratios and the presence and severity of psoriasis: a systematic review and meta-analysis
  107. Circulating serotonin levels in COPD patients: a pilot study
  108. Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis
  109. Red blood cell distribution width in pregnancy: a systematic review
  110. Oxidative stress-linked biomarkers in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
  111. Re: Neutrophil-to-lymphocyte ratio predicts anastomotic dehiscence
  112. Homoarginine and all-cause mortality: A systematic review and meta-analysis
  113. Systemic inflammation indexes predict response to immunotherapy in patients with lung cancer
  114. Coronary flow reserve in systemic rheumatic diseases: a systematic review and meta-analysis
  115. Predictors of hospital stay in thoracic surgery
  116. Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review
  117. Markers of oxidative stress, skeletal muscle mass and function, and their responses to resistance exercise training in older adults
  118. Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives
  119. Genetic alterations in main candidate genes during melanoma progression
  120. Spontaneous Release of Human Serum Albumin S-Bound Homocysteine in a Thiol-Free Physiological Medium
  121. Vitamin D status and risk for malignant cutaneous melanoma
  122. Female Adnexal Tumors of Probable Wolffian Origin (FATWO)
  123. Predictive Values of C-Reactive Protein and Neutrophil to Lymphocyte Ratio in Detecting Anastomotic Leak in Open Colorectal Surgery
  124. Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis
  125. Desmoplastic small round cell tumors of the pleura: a review of the clinical literature
  126. Wirsung Duct Occlusion Versus Pancreaticojejunostomy after Pancreaticoduodenectomy
  127. VATS Thymectomy with 3D Vision: A Chance to Further Improve the Outcomes of Thymus Minimally Invasive Surgery
  128. Mutation analysis of mucosal and cutaneous melanomas during progression.
  129. Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy
  130. Noncoding RNAs in Gallbladder Cancer
  131. Long non-coding RNA CASC2 in human cancer
  132. Perivascular Epithelioid Cell Tumors (PEComas) of the Orbit
  133. Deciduoid mesothelioma of the thorax: A comprehensive review of the scientific literature
  134. Evaluation of Global Genomic DNA Methylation in Human Whole Blood by Capillary Electrophoresis UV Detection
  135. Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
  136. Low Levels of Genetic Heterogeneity in Matched Lymph Node Metastases from Patients with Melanoma
  137. Impact of novel histopathological factors on the outcomes of liver surgery for colorectal cancer metastases
  138. Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
  139. Thoracoscopic treatment of a broncho-esophageal fistula: A case report
  140. Breast Nodular Fasciitis: A Comprehensive Review
  141. Nonfunctional paraganglioma of the head of the pancreas: A rare case report
  142. Small bowel emergencies: two surgical centers’ experience and literature review
  143. Disease progression and overall survival in sardinian patients with colorectal cancer according to the kras mutational status
  144. Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from sardinia
  145. Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic Targets
  146. Impact of tissue type and content of neoplastic cells of samples on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma
  147. Robotic left ventricular epicardial lead positioning
  148. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway
  149. KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma
  150. An unusual case of excessive sweating affecting the right upper limb after bilateral endoscopic thoracic sympathectomy for primary palmar hyperhidrosis: recurrence or compensatory hyperhidrosis?
  151. Discrepant alterations in main candidate genes among multiple primary melanomas
  152. Primär dermales Melanom bei einer Patientin mit multiplen Malignomen in der Vorgeschichte: Ein Fallbericht mit molekularer Charakterisierung
  153. Radiofrequency Ablation in the Management of Advanced Stage Thymomas: A Case Report on a Novel Multidisciplinary Therapeutic Approach
  154. Hybrid transanal endoscopic microsurgery: a novel approach to rectal neoplasm excision
  155. Primary Dermal Melanoma in a Patient with a History of Multiple Malignancies: A Case Report with Molecular Characterization
  156. Molecular analysis of appendiceal mucinous cystadenoma and rectal adenocarcinoma in a patient with urothelial carcinoma: a case report
  157. The “virtual ileostomy” in elective colorectal surgery: is it useful?
  158. Unexpected Distribution ofcKITandBRAFMutations among Southern Italian Patients with Sinonasal Melanoma
  159. Epidemiology of Thyroid Cancer in an Area of Epidemic Thyroid Goiter
  160. Lung cancer epidemiology in North Sardinia, Italy
  161. Impact of Age on the Quality of Lymphadenectomy for Colorectal Cancer
  162. Single access videothoracoscopic biopsy and talc pleurodesis in patients with malignant pleural effusion
  163. Low-Grade Fibromatosis-Like Spindle Cell Metaplastic Carcinoma of the Breast: A Case Report and Literature Review
  164. Warthin-Like Papillary Carcinoma of the Thyroid Gland: Case Report and Review of the Literature
  165. Axillary Lymph Node Dissection in Patients with Breast Cancer and Sentinel Lymph Node Micrometastasis or Isolated Tumor Cells: Is it Necessary?
  166. T2–T4 sympathectomy versus T3–T4 sympathicotomy for palmar and axillary hyperhidrosis